Closed
SectorHealthcare
308.58 0.32
24h
Min
300.12
Max
309.25
Income | 26M -57M |
---|---|
Sales | 1M 594M |
EPS | -0.01 |
Profit margin | -9.674 |
Employees | 2,230 |
EBITDA | 166M 11M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +6.63% upside |
Next Earnings | 31 Jul 2025 |
---|
Market Cap | 5.5B 40B |
---|---|
Previous open | 308.26 |
Previous close | 308.58 |
By Acuity
50%
50%
164 / 381 Healthcare
By Trading Central
Confidence
Bullish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 328.41 USD 6.63%
High 500 USD
Low 245 USD
Based on 23 Wall Street analysts offering 12 month price targets forAlnylam Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$